BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22421144)

  • 1. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
    Sikka A; Kaur M; Agarwal C; Deep G; Agarwal R
    Cell Cycle; 2012 Apr; 11(7):1374-82. PubMed ID: 22421144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
    Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.
    Prasad R; Katiyar SK
    PLoS One; 2012; 7(9):e46404. PubMed ID: 23050025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck.
    Gedlicka C; Hager G; Weissenböck M; Gedlicka W; Knerer B; Kornfehl J; Formanek M
    J Oral Pathol Med; 2006 Sep; 35(8):472-8. PubMed ID: 16918598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo.
    Zhu L; Luo Q; Bi J; Ding J; Ge S; Chen F
    Chem Biol Interact; 2014 Dec; 224():149-56. PubMed ID: 25450235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
    Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
    PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway.
    Macha MA; Rachagani S; Pai P; Gupta S; Lydiatt WM; Smith RB; Johansson SL; Lele SM; Kakar SS; Farghaly H; Lee JH; Meza J; Ganti AK; Jain M; Batra SK
    Oncogene; 2015 Mar; 34(13):1698-708. PubMed ID: 24747969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer.
    Cheng F; Zagon IS; Verderame MF; McLaughlin PJ
    Cancer Res; 2007 Nov; 67(21):10511-8. PubMed ID: 17974995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells.
    Zhao L; Wen ZH; Jia CH; Li M; Luo SQ; Bai XC
    Anat Rec (Hoboken); 2011 Aug; 294(8):1337-43. PubMed ID: 21717584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
    Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G
    PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
    Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
    Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gadhikar MA; Zhang J; Shen L; Rao X; Wang J; Zhao M; Kalu NN; Johnson FM; Byers LA; Heymach J; Hittelman WN; Udayakumar D; Pandita RK; Pandita TK; Pickering CR; Redwood AB; Piwnica-Worms H; Schlacher K; Frederick MJ; Myers JN
    Cancer Res; 2018 Feb; 78(3):781-797. PubMed ID: 29229598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.
    Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H
    PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma.
    Ku BM; Yi SY; Koh J; Bae YH; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Oncotarget; 2016 Mar; 7(12):14803-13. PubMed ID: 26909611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
    Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
    Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.